ABSTRACT
O objetivo deste relato é descrever um caso de degeneração macular relacionada à idade com presença de membrana neovascular sub-retiniana (MNVSR) justafoveal, tratada inicialmente com bevacizumab (Avastin®) intravítrea e posteriormente com terapia de fotocoagulação focal (TFC) com laser. A eficácia do tratamento inicial e complementar foi avaliada pela medida da acuidade visual e por exames complementares (angiografia fluoresceínica e tomografia de coerência óptica). Após três injeções intravítreas de bevacizumab ocorreu a redução excêntrica da MNVSR, alterando sua classificação para extrafoveal, o que permitiu o tratamento subsequente com TFC.
The aim of this report is to describe a case of age-related macular degeneration with juxtafoveal subretinal neovascular membrane, initially treated with intravitreal bevacizumab (Avastin®) and afterwards with focal photocoagulation laser therapy. The efficacy of the initial and complementary treatment was evaluated through the visual acuity measurement and complementary exams (fluorescein angiography and optical coherence tomography). After three bevacizumab intravitreal injections , it has occurred the eccentric reduction of the neovascular subretinal membrane, changing its classification to extrafoveal, what allowed the subsequent treatment with focal photocoagulation laser therapy.
Subject(s)
Aged , Humans , Male , Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Light Coagulation , Retinal Neovascularization/therapy , Combined Modality Therapy/methods , Fluorescein Angiography , Retinal Neovascularization/diagnosis , Tomography, Optical Coherence , Treatment OutcomeABSTRACT
RESUMO O objetivo deste relato é descrever um caso de síndrome iridocorneana endotelial, na variante clínica atrofia essencial de íris, com concomitante hipertrofia congênita do epitélio pigmentar da retina no mesmo olho.
The aim of this report is to describe a case of iridocornel endothelial syndrome with the clinical variant essential iris atrophy, which presents concomitant congenital hypertrophy of the retinal pigment epithelium in the same eye.